The board of directors of China Regenerative Medicine International Limited announced Dr. Sun Xiaohu has been appointed as the chief operating officer of the Company with effect from 10 October 2018. Dr. Sun has 36 years' experience in listed biotechnology companies, pharmaceutical companies, medical enterprises, research institutes and hospitals; and 18 years' experience as chief executive officers and senior executives in domestic and international pharmaceutical and medical device companies.